IRIS
FRANZESE, Ciro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.782
AS - Asia 3.350
EU - Europa 1.368
SA - Sud America 1.231
AF - Africa 226
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 9
Totale 12.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.687
SG - Singapore 1.925
BR - Brasile 1.032
CN - Cina 678
VN - Vietnam 327
FI - Finlandia 293
IE - Irlanda 232
DE - Germania 170
IT - Italia 158
NG - Nigeria 153
HK - Hong Kong 109
FR - Francia 106
GB - Regno Unito 89
SE - Svezia 80
AR - Argentina 76
NL - Olanda 73
IN - India 67
CA - Canada 55
RU - Federazione Russa 40
BD - Bangladesh 37
EC - Ecuador 37
TR - Turchia 33
ID - Indonesia 30
CO - Colombia 28
IL - Israele 26
MX - Messico 25
AU - Australia 22
ZA - Sudafrica 22
BE - Belgio 19
IQ - Iraq 19
PL - Polonia 19
CL - Cile 18
VE - Venezuela 17
UZ - Uzbekistan 16
UA - Ucraina 15
PY - Paraguay 13
AT - Austria 12
KE - Kenya 12
CZ - Repubblica Ceca 10
EG - Egitto 10
JP - Giappone 10
PK - Pakistan 10
ES - Italia 9
MA - Marocco 9
TN - Tunisia 9
KZ - Kazakistan 8
OM - Oman 8
RO - Romania 7
SA - Arabia Saudita 7
A2 - ???statistics.table.value.countryCode.A2??? 6
IR - Iran 6
LT - Lituania 6
PE - Perù 6
AZ - Azerbaigian 5
GR - Grecia 5
JO - Giordania 5
NO - Norvegia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
DZ - Algeria 4
HN - Honduras 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
EU - Europa 3
NP - Nepal 3
PA - Panama 3
PS - Palestinian Territory 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BW - Botswana 2
CH - Svizzera 2
GE - Georgia 2
HR - Croazia 2
KG - Kirghizistan 2
MY - Malesia 2
RS - Serbia 2
TZ - Tanzania 2
UY - Uruguay 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
GD - Grenada 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 12.989
Salva come PNG Salva come JPEG
Città #
Wilmington 1.080
Dallas 927
Chandler 761
Singapore 618
The Dalles 467
San Mateo 411
Shanghai 400
Helsinki 292
Ann Arbor 287
Dublin 231
Ashburn 198
Leawood 198
Boardman 195
Lawrence 186
Princeton 186
Beijing 154
Benin City 153
Woodbridge 121
Ho Chi Minh City 117
New York 113
Fairfield 107
Hong Kong 92
Paris 92
São Paulo 90
Milan 71
Hanoi 67
Amsterdam 63
London 45
Los Angeles 39
Rio de Janeiro 38
Seattle 33
Toronto 29
Belo Horizonte 26
Norwalk 26
Kocaeli 25
Santa Clara 25
Porto Alegre 19
Brussels 18
Haiphong 17
Monmouth Junction 16
Munich 16
Curitiba 15
Brasília 14
Chennai 14
Fortaleza 14
Phoenix 14
San Diego 14
Da Nang 13
Guayaquil 13
Naples 13
Orem 13
Ribeirão Preto 13
Tashkent 13
Warsaw 13
Brooklyn 12
Des Moines 11
Johannesburg 11
Milwaukee 11
Montreal 10
Pune 10
Quito 10
Santo André 10
Tokyo 10
Boston 9
Nairobi 9
Nuremberg 9
Salvador 9
San Francisco 9
Thái Bình 9
Biên Hòa 8
Council Bluffs 8
Dhaka 8
Falkenstein 8
Guarulhos 8
Joinville 8
Mauá 8
Mexico City 8
Nova Iguaçu 8
Redwood City 8
São Bernardo do Campo 8
Vienna 8
Asunción 7
Bogotá 7
Campinas 7
Can Tho 7
Duque de Caxias 7
Goiânia 7
Medellín 7
Recife 7
Sorocaba 7
Thái Nguyên 7
Baghdad 6
Bathurst 6
Bauru 6
Betim 6
Brno 6
Buenos Aires 6
Cairo 6
Cape Town 6
Chicago 6
Totale 8.594
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 610
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 112
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 109
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 104
Accuracy of fine-needle aspiration cytology in detecting cervical node metastasis after radiotherapy: Systematic review and meta-analysis 103
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 99
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 93
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. 91
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 89
Concomitant adjuvant chemo-radiation therapy with anthracyclinebased regimens in breast cancer: a single centre experience 89
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 88
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 86
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 84
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 82
Management of inflammatory breast cancer: Focus on radiotherapy with an evidence-based approach 82
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 80
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 79
Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases 79
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 78
Hypofractionated stereotactic radiation therapy in skull base meningiomas 76
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 76
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 73
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 72
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 72
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 71
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 71
SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients 71
STEREOTACTIC BODY RADIATION THERAPY AS LOCAL TREATMENT FOR OLIGOMETASTASES FROM PROSTATE CANCER: EFFICACY AND IMPACT ON SYSTEMIC TREATMENT 70
Adenoid cystic carcinoma of the breast The double face of an exocrine gland carcinoma 68
Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial 66
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients. 66
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 66
Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series 66
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group 65
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer 65
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 65
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 64
Randomized phase II study of hypofractionated WBI versus APBI using VMAT: early toxicity results 64
Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis 64
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 64
Discrepancies between UICC and AJCC TNM classifications for oral cavity tumors in the 8th editions and following versions 63
Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis. 63
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 63
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 63
Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution 62
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent. 62
RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies 62
RE-IRRADIATION OF LOCALLY RECURRENT PROSTATE CANCER: RESULTS OF EFFICACY AND SAFETY 61
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 61
SBRT for oligometastatic gynecological cancer: a single institution experience 61
Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients. 61
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? 61
Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome 60
LINAC-BASED STEREOTACTIC RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER: 4-YEAR FOLLOW-UP UPDATE ON TOXICITY AND SURVIVAL 60
Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer. 60
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. 60
Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 Study 60
Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases? 60
Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy 59
Role of preoperative radiotherapy in rare retroperitoneal sarcoma 59
The role of SBRT in oligometastatic patients with liver metastases from breast cancer 59
Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity 59
Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy. 59
Role of C-11-CHOLINE PET/CT in the Radiotherapy Treatment Planning of Prostate Cancer Patients 59
HYPOFRACTIONATED RADIATION THERAPY (OVER 3 WEEKS) CAN REPLACE CONVENTIONAL RADIATION THERAPY SCHEDULE (OVER 6 WEEKS) IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS? THE TIMES ARE RIPE 59
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery. 58
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience 58
RapidPlan head and neck model: the objectives and possible clinical benefit. 58
Results of a feed-back learning process for RapidPlan knowledge based planning 58
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors 58
Moderate hypofractionation and SIB with volumetric modulated arc therapy (RapidArc) for anal cancer 58
Role of SBRT with VMAT technique and FFF beams for lymph-node metastases in oligometastatic patients from genitourinary malignancies 58
Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy 58
Randomized Phase III Trial Comparing Gamma Knife and Linac Based (EDGE) Approaches for Brain Metastases Radiosurgery: Results from the Gadget Trial 57
Hypofractionated radiotherapy for ductal carcinoma in situ using VMAT: acute toxicity and cosmesis 57
GAMMAKNIFE VERSUS LINAC BASED (EDGE) RADIOSURGERY (SRS) FOR PATIENTS WITH LIMITED BRAIN METASTASES (BMS) FROM DIFFERENT SOLID TUMOR: A PHASE III RANDOMIZED TRIAL 57
Oligometastatic colorectal cancer in elderly patients: role of stereotactic body radiation therapy 57
Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis 57
Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study 57
ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial (vol 13, 166, 2018) 56
Role of stereotactic body radiation therapy in the management of oligometastatic pancreatic cancer single institution experience 56
Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy. 56
Stereotactic Body Radiation Therapy for oligometastatic patients with ovarian cancer 56
Low Prevalence of K-RAS, EGF-R and BRAF Mutations in Sinonasal Adenocarcinomas. Implications for Anti-EGFR Treatments 56
Role of SBRT in the treatment of liver metastases: clinical results and prognostic factors 56
Imaging biomarkers in primary brain tumours 56
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma 55
Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy 55
Critical Appraisal of the Treatment Planning Performance of Volumetric Modulated Arc Therapy by Means of a Dual Layer Stacked Multileaf Collimator for Head and Neck, Breast, and Prostate 55
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial 55
SABR in inoperable liver oligometastatic patients and radioresistant primary tumors 55
Role of extra cranial stereotactic body radiation therapy in the management of Stage IV melanoma 54
Role of Radiotherapy in the management of metastases from salivary gland carcinoma. 54
HYPOFRACTIONATED STEREOTACTIC RADIATION THERAPY (HSRT) IN SKULL BASE MENINGIOMAS 54
Does Tumor Volume Have a Prognostic Role in Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis 53
Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy. 53
Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature 53
Stereotactic Body Radiation Therapy in Oligometastatic Ovarian Cancer A Promising Therapeutic Approach 53
Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University 53
Influence of "radioresistant" histologies on SBRT outcome for lung metastases 53
Totale 7.141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.163
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.888 0 0 0 0 0 601 263 149 445 220 8 202
2021/2022983 62 7 8 217 6 4 42 150 88 89 278 32
2022/20232.300 401 84 230 242 192 163 1 173 405 229 162 18
2023/20241.463 72 167 327 80 45 145 58 70 70 32 152 245
2024/20252.459 51 89 33 33 23 276 121 226 381 644 254 328
2025/20263.977 1.025 610 1.003 1.060 214 65 0 0 0 0 0 0
Totale 13.212